Andy Lee is Co-founder and Chief Business Officer of Vincere Biosciences, where he has led fundraising, BD, and IP strategy to advance first-in-class mitophagy-enhancing therapeutics. A co-inventor on multiple patents, Andy bridges 20+ years of experience in AI-driven systems engineering with translational drug development. He has raised over $10M in equity funding and forged strategic partnerships across pharma and aging biotech to accelerate treatments for neurodegeneration, kidney disease, and age-related decline.